PRMA Consulting Ltd
http://prmaconsulting.co.ukPRMA Consulting provides best in class strategic, commercial and technical based pricing, reimbursement and market access advisory services to companies to overcome their global and local market access hurdles. Our clients include the top 20 pharmaceutical companies, biotechnology, medical device and diagnostic companies, venture capital and private equity firms. PRMA Consulting, founded in 2006, is a dynamic consultancy experiencing rapid growth. We work in partnership with clients to ensure projects are executed to the highest standard, on time and to budget, whilst delivering flexibility and adaptability in recognition of changing situations and needs. PRMA Consulting undertakes pricing and reimbursement due diligence to ensure all market access risks have been fully assessed and maximum product value is delivered. We offer strategic, technical and operational consultancy to support Health Outcomes business objectives and we have significant experience of conducting real world observational studies both at pre- and post-launch phase. Our partners and consultants bring hands-on experience of the strategic, commercial and technical market access challenges faced across the healthcare industry today as well as full geographic and therapeutic area coverage.
Area of focus:
Health Outcomes, Licensing & Acquisitions, Market Access, Observational Studies, Pricing & Reimbursement
Leading Experts at PRMA Consulting Ltd(?)
Total Experts: 1Principal
David Sykes is the Principal of PRMA Consulting, United Kingdom. He is an expert in pricing, reimbursement, and health outcomes within pharmaceutical and medical device sectors. Mr. Sykes has over 12 years of blue chip experience at J&J, Lilly, and Organon within global, European and UK roles. He has...
GLG NewsSMAnalyses by Leading Experts at PRMA Consulting Ltd(?)
Top 5 Recent NewsExubera is the first major product to fail primarily due to Pfizer's inability to convince payors of it's value for money There is now significant additional risk in achieving market access after regulatory approval. Pricing and reimbursement decisions will play an increasingly important role in the commercial success of companies going forward.
GLG Study Groups Relevent to Leading Experts at PRMA Consulting Ltd(?)
| Top 5 Study Groups | Members |
|---|
| Generic Pharmaceuticals Economic Experts (Germany) | 41 |
| Biopharmaceutical Reimbursement Experts (EU) | 15 |
Events Hosted by Leading Experts at PRMA Consulting Ltd(?)
Total Events: 0View All GLG Seminars in Healthcare

